Telemedicine uses videoconferencing technologies to enable remote medical treatment and consultations, helping to increase access to specialists and reduce costs. It allows hospitals to treat more patients using existing resources and facilities. While telemedicine faces challenges around reimbursement and changing medical practices, its implementation could improve healthcare by enhancing access to care and reducing travel burdens for patients.
GlobalMed provides telemedicine solutions worldwide through partnerships in over 55 countries. They offer integrated telemedicine ecosystems including medical peripherals, software, and education/training to support remote healthcare delivery. Case studies demonstrate successful implementations across various specialties and countries, improving access to care through technologies like ultrasound, stethoscopes, and spirometers.
The document provides an overview of a typical day for a primary care physician at the Heartland Clinic of Platte City. It discusses the physician's schedule, use of electronic medical records, remote access capabilities, messaging with patients, clinical decision making, interruptions, and use of ePrescribing. It also outlines opportunities for innovative technologies, such as improving drug selection, pharmacy selection, and enabling real-time connections between prescribing systems and additional resources for physicians and patients.
Healthcare Communications Study Among Physicians: Medical Monitor 2013Joshua Spiegel
Where do physicians get their information? What’s the best way to reach these important healthcare stakeholders? Find out with our Physician Healthcare Communications report.
How do patients learn and seek healthcare information? What influence does technology have on patient healthcare communication? Our Patient Healthcare Communications report explores the answers to these questions and more.
e-detailing: effective promotion of professional science communication Merqurio
The evolution of new information and communication technologies (ICT) has designed an innovative model to transmit data in the healthcare field.
This model can support the health care and administrative processes of companies, management of the relationship between patients and facilities and, lastly, medical and scientific information.
Wearables-Provider-Research_iTriage November 2015Peggy Lawless
- The survey found that most providers have adopted several patient-facing technologies like patient portals and secure email. Remote patient monitoring devices for chronic disease management are also increasingly used.
- While video visits are still not widely adopted, increased access to care is seen as the top benefit and over half of providers plan to offer it within two years.
- Providers working in accountable care organizations are more likely to embrace new technologies than other providers.
We live in an era of technologic advancements. Dentistry is no behind in this era. Here is a brief sum up of teledentistry and its applications in the field.
Telemedicine uses videoconferencing technologies to enable remote medical treatment and consultations, helping to increase access to specialists and reduce costs. It allows hospitals to treat more patients using existing resources and facilities. While telemedicine faces challenges around reimbursement and changing medical practices, its implementation could improve healthcare by enhancing access to care and reducing travel burdens for patients.
GlobalMed provides telemedicine solutions worldwide through partnerships in over 55 countries. They offer integrated telemedicine ecosystems including medical peripherals, software, and education/training to support remote healthcare delivery. Case studies demonstrate successful implementations across various specialties and countries, improving access to care through technologies like ultrasound, stethoscopes, and spirometers.
The document provides an overview of a typical day for a primary care physician at the Heartland Clinic of Platte City. It discusses the physician's schedule, use of electronic medical records, remote access capabilities, messaging with patients, clinical decision making, interruptions, and use of ePrescribing. It also outlines opportunities for innovative technologies, such as improving drug selection, pharmacy selection, and enabling real-time connections between prescribing systems and additional resources for physicians and patients.
Healthcare Communications Study Among Physicians: Medical Monitor 2013Joshua Spiegel
Where do physicians get their information? What’s the best way to reach these important healthcare stakeholders? Find out with our Physician Healthcare Communications report.
How do patients learn and seek healthcare information? What influence does technology have on patient healthcare communication? Our Patient Healthcare Communications report explores the answers to these questions and more.
e-detailing: effective promotion of professional science communication Merqurio
The evolution of new information and communication technologies (ICT) has designed an innovative model to transmit data in the healthcare field.
This model can support the health care and administrative processes of companies, management of the relationship between patients and facilities and, lastly, medical and scientific information.
Wearables-Provider-Research_iTriage November 2015Peggy Lawless
- The survey found that most providers have adopted several patient-facing technologies like patient portals and secure email. Remote patient monitoring devices for chronic disease management are also increasingly used.
- While video visits are still not widely adopted, increased access to care is seen as the top benefit and over half of providers plan to offer it within two years.
- Providers working in accountable care organizations are more likely to embrace new technologies than other providers.
We live in an era of technologic advancements. Dentistry is no behind in this era. Here is a brief sum up of teledentistry and its applications in the field.
Teledentistry uses telecommunications and information technologies to provide dental care, consultation, education, and public awareness from a distance. It has benefits like improving access to care, lowering costs, and being a needed resource for dental consulting and referrals. Teledentistry involves real-time video consultations or storing and forwarding patient information and images for later review. It uses technologies like digital cameras, videoconferencing, and radiography connected through networks, computers, and software. Teledentistry has various applications in fields like oral medicine, prosthodontics, pediatrics, endodontics, and more that can improve diagnosis and care for remote populations.
This document provides an overview of teledentistry, including definitions, benefits, applications, technologies used, and examples of implementation. Teledentistry is defined as the use of telecommunications technology to provide dental care remotely. It can improve access to care, especially in rural areas, and lower costs. Key applications discussed include teleconsultations, remote patient monitoring, education and training. The document reviews technologies like videoconferencing and digital imaging that enable teledentistry. Examples from countries like the US, Australia and India demonstrate how teledentistry has been adopted to expand access to dental services. Challenges and the future potential of teledentistry are also discussed.
Teledentistry can be defined as the remote provision of dental care, advice, or treatment through the medium of information technology, rather than through direct personal contact with the patient involved. Within the dental practice, it is used extensively in disciplines such as preventive dentistry, orthodontics, endodontics, oral surgery dental periodontal conditions, and detection of early dental caries patient education, oral medicine and diagnosis. Some of the key modes and methods used today are electronic health records, electronic referral systems digitizing images, teleconsultations, and telediagnosis. It is very effective is to bring about efficiency provide access to underserved populations, improve quality of care and reduce of oral disease burden.
Teledentistry is a turnkey solution that allows dental practices to provide remote dental care using telecommunication technologies. It offers many benefits such as attracting new patients, increasing revenue, providing convenient access to care, and improving documentation for insurance claims. The Teledent system includes all necessary hardware and software for dental practices and clinicians to easily implement teledentistry using live streaming or stored medical images and data. It is a cost-effective way for practices to expand their reach and better serve the oral health needs of their communities.
This document summarizes 10 health innovations and trends to watch in 2010, including: 1) "Hello Health" franchised primary care practices with online tools and direct payments, 2) use of surgical checklists to improve safety, 3) mobile health applications like HealthMap for disease surveillance, 4) direct-to-consumer genetic testing providing personalized health information, 5) "reverse innovations" developed first for emerging markets, 6) services generating personalized care plans from health data, 7) point-of-care diagnostic technologies, 8) the University of Toronto's crowdsourcing of health system ideas, 9) the growth of mobile health applications, and 10) patient data sharing communities like PatientsLikeMe. These innovations aim to improve health
Teledentistry platforms connect dentists to each other and to patients for real-time consultations, via live stream or video conferencing. These opportunities for collaboration lead to faster treatment plans and more efficient care delivery.
Teledentistry; Next step into digitalizationKathan Mehta
Today, oral health is recognized to play an integral role in overall well-being and quality of life.
Despite all the efforts to achieve society with optimal oral hygiene, the rural areas of our country has
many barriers to access dental services because of geographic remoteness, poor or no public
transportation, less information about dental hygiene and lack of avaibility of specialized health care
professionals leading to failure in implementing effective oral health care. In recent years, due to push
of digitalization by government and use of computer and latest telecommunication technology have
dramatically uplifted the entire health care system including dentistry to altogether a new level. In
modern era, new opportunities are being provided for easy access to primary care professionals for
proficient consultation by teledentistry. Use of teledentistry can contribute to bridge the gap between
demand and supply of dental care facilities. Following paper presents overview regarding enormous
scope of telecommunication in providing dental education and primary health care delivery.
A lot of dentists are still hesitant to make a move towards the digitalization of their clinical practice. However, the increasing importance and use of teledentistry is encouraging and shows a lot of promise to develop the field of dentistry. It has shown a significant use in networking, consultations, dental records sharing, and aiding in para clinical procedures.
TeleDent is a teledentistry solution that allows public health programs, schools, and clinics to improve oral health care through remote screenings and evaluations. By using TeleDent's telehealth tools, programs can reach more people in need of oral healthcare, including over 16 million children with untreated tooth decay. TeleDent streamlines the screening process and allows dentists to remotely evaluate patients and discuss treatment through live video calls and secure sharing of diagnostic images. This solution expands access to affordable oral healthcare while improving efficiency for providers.
Telemedicine in the Healthcare Delivery SystemVSee
For more information of the presentation such as recording and transcript, please visit:
https://goo.gl/yiQNAA
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
Yuri Quintana of BIDMC - November 11th Health Innovators Presentationmlkrgr
This is Yuri Quintana's presentation from November 11th's Health Innovators event "Leveraging Innovation to Improve Medication Adherence".
Please see more information about Health Innovators at http://www.healthinno.org.
Please visit http://www.bidmc.org/ to see more information about BIDMC
1. The presenters were Paul O’Donohoe, Director of Health Outcomes at CRF Health, and Jennifer Crager, who has over 13 years of experience in the eCOA industry.
2. Bring Your Own Device (BYOD) involves using participants' own internet-connected devices like smartphones to complete electronic patient-reported outcomes, rather than providing hardware. Interest in BYOD is driven by potential reduced costs and increased participant convenience and compliance.
3. However, BYOD also presents challenges including demonstrating measurement equivalence across many different devices, providing technical support, ensuring privacy and security, and reimbursing participants for data usage. Future adoption of BYOD in clinical trials will require addressing these challenges.
This document outlines guidelines for telemedicine in India. It discusses the need for telemedicine, different modes of communication, guidelines issued by the Ministry of Health and Family Welfare, the framework and technology platforms for telemedicine. It also discusses success stories, challenges, and scenarios where telemedicine can be used, such as between patients and doctors, caregivers and doctors, health workers and doctors, and doctors consulting each other. The document provides detailed guidelines on the practice of telemedicine in India.
This survey of 300 doctors in Greater Jakarta area found that:
1) Online media is the most trusted source of medical information for doctors, followed by medical journals and seminars.
2) The internet has significantly influenced doctors' practice by allowing them to obtain information faster and be more active in seeking and sharing information.
3) Patients are increasingly looking up health information online, making them more informed but also more opinionated. Doctors have had to improve communication to discuss information patients find online.
4) While the internet provides many benefits, patient education remains a challenge requiring materials and training for doctors in properly educating patients.
Telemedicine is defined as using telecommunications to provide healthcare remotely by sharing medical information and expertise over distances. It involves transferring various medical data like images, sounds, and patient records via internet, intranet, computers, and telephone lines. Some key applications of telemedicine include teleconsultation, telemonitoring of patients, telediagnosis, and tele-education of medical practitioners. While telemedicine provides benefits like improved access to care and cost savings, its adoption faces challenges due to issues around technology infrastructure, licensing, and patient acceptance of remote healthcare.
ePRO_Presentation_BYOD Webinar_5 Final 9 March 2016 YPrimeCindy Howry, MS
This document summarizes a presentation on Bring Your Own Device (BYOD) for electronic clinical outcome assessments (eCOAs) in clinical trials. It discusses the growing interest in BYOD due to smartphone saturation and perceived benefits. There are two main types of BYOD apps: native apps downloaded from app stores and web apps accessed through mobile browsers. While BYOD could reduce costs and burden, challenges include demonstrating measurement equivalence across different devices, addressing logistical concerns, ensuring patient privacy and security, developing and supporting mobile apps, and reimbursing patients for data usage. Moving forward, these challenges can be overcome through careful study design, choice of appropriate app technologies, support structures, and patient reimbursement.
Telemedicine has moved to the forefront of healthcare, opening up opportunities for both practices and their patients. To help unpack some of the enormous amounts of new information, This presentation focuses on:
- Relaxing of Regulatory Issues
- How Telemedicine Can Help Your Practice
- Challenges
- The Future of Telemedicine
Craig lipset, Director of Clinical Research
at Pfi zer, leads a panel discussion on the
current state of clinical trials and the use
of technology to capture the voice of the
patient. Th e panelists, coming from various
backgrounds, lend their diff ering viewpoints
on the current and future trends in
this space
Mobile Phones - Always there and always on ! Vikrant Patnaik
mHealth is catching up and is now being considered to be used globally not only in the area of healthcare but also in the Pharma and Life sciences areas. This document speaks briefly about how mobility can be effectively used in Clinical Trials.
Teledentistry uses telecommunications and information technologies to provide dental care, consultation, education, and public awareness from a distance. It has benefits like improving access to care, lowering costs, and being a needed resource for dental consulting and referrals. Teledentistry involves real-time video consultations or storing and forwarding patient information and images for later review. It uses technologies like digital cameras, videoconferencing, and radiography connected through networks, computers, and software. Teledentistry has various applications in fields like oral medicine, prosthodontics, pediatrics, endodontics, and more that can improve diagnosis and care for remote populations.
This document provides an overview of teledentistry, including definitions, benefits, applications, technologies used, and examples of implementation. Teledentistry is defined as the use of telecommunications technology to provide dental care remotely. It can improve access to care, especially in rural areas, and lower costs. Key applications discussed include teleconsultations, remote patient monitoring, education and training. The document reviews technologies like videoconferencing and digital imaging that enable teledentistry. Examples from countries like the US, Australia and India demonstrate how teledentistry has been adopted to expand access to dental services. Challenges and the future potential of teledentistry are also discussed.
Teledentistry can be defined as the remote provision of dental care, advice, or treatment through the medium of information technology, rather than through direct personal contact with the patient involved. Within the dental practice, it is used extensively in disciplines such as preventive dentistry, orthodontics, endodontics, oral surgery dental periodontal conditions, and detection of early dental caries patient education, oral medicine and diagnosis. Some of the key modes and methods used today are electronic health records, electronic referral systems digitizing images, teleconsultations, and telediagnosis. It is very effective is to bring about efficiency provide access to underserved populations, improve quality of care and reduce of oral disease burden.
Teledentistry is a turnkey solution that allows dental practices to provide remote dental care using telecommunication technologies. It offers many benefits such as attracting new patients, increasing revenue, providing convenient access to care, and improving documentation for insurance claims. The Teledent system includes all necessary hardware and software for dental practices and clinicians to easily implement teledentistry using live streaming or stored medical images and data. It is a cost-effective way for practices to expand their reach and better serve the oral health needs of their communities.
This document summarizes 10 health innovations and trends to watch in 2010, including: 1) "Hello Health" franchised primary care practices with online tools and direct payments, 2) use of surgical checklists to improve safety, 3) mobile health applications like HealthMap for disease surveillance, 4) direct-to-consumer genetic testing providing personalized health information, 5) "reverse innovations" developed first for emerging markets, 6) services generating personalized care plans from health data, 7) point-of-care diagnostic technologies, 8) the University of Toronto's crowdsourcing of health system ideas, 9) the growth of mobile health applications, and 10) patient data sharing communities like PatientsLikeMe. These innovations aim to improve health
Teledentistry platforms connect dentists to each other and to patients for real-time consultations, via live stream or video conferencing. These opportunities for collaboration lead to faster treatment plans and more efficient care delivery.
Teledentistry; Next step into digitalizationKathan Mehta
Today, oral health is recognized to play an integral role in overall well-being and quality of life.
Despite all the efforts to achieve society with optimal oral hygiene, the rural areas of our country has
many barriers to access dental services because of geographic remoteness, poor or no public
transportation, less information about dental hygiene and lack of avaibility of specialized health care
professionals leading to failure in implementing effective oral health care. In recent years, due to push
of digitalization by government and use of computer and latest telecommunication technology have
dramatically uplifted the entire health care system including dentistry to altogether a new level. In
modern era, new opportunities are being provided for easy access to primary care professionals for
proficient consultation by teledentistry. Use of teledentistry can contribute to bridge the gap between
demand and supply of dental care facilities. Following paper presents overview regarding enormous
scope of telecommunication in providing dental education and primary health care delivery.
A lot of dentists are still hesitant to make a move towards the digitalization of their clinical practice. However, the increasing importance and use of teledentistry is encouraging and shows a lot of promise to develop the field of dentistry. It has shown a significant use in networking, consultations, dental records sharing, and aiding in para clinical procedures.
TeleDent is a teledentistry solution that allows public health programs, schools, and clinics to improve oral health care through remote screenings and evaluations. By using TeleDent's telehealth tools, programs can reach more people in need of oral healthcare, including over 16 million children with untreated tooth decay. TeleDent streamlines the screening process and allows dentists to remotely evaluate patients and discuss treatment through live video calls and secure sharing of diagnostic images. This solution expands access to affordable oral healthcare while improving efficiency for providers.
Telemedicine in the Healthcare Delivery SystemVSee
For more information of the presentation such as recording and transcript, please visit:
https://goo.gl/yiQNAA
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
Yuri Quintana of BIDMC - November 11th Health Innovators Presentationmlkrgr
This is Yuri Quintana's presentation from November 11th's Health Innovators event "Leveraging Innovation to Improve Medication Adherence".
Please see more information about Health Innovators at http://www.healthinno.org.
Please visit http://www.bidmc.org/ to see more information about BIDMC
1. The presenters were Paul O’Donohoe, Director of Health Outcomes at CRF Health, and Jennifer Crager, who has over 13 years of experience in the eCOA industry.
2. Bring Your Own Device (BYOD) involves using participants' own internet-connected devices like smartphones to complete electronic patient-reported outcomes, rather than providing hardware. Interest in BYOD is driven by potential reduced costs and increased participant convenience and compliance.
3. However, BYOD also presents challenges including demonstrating measurement equivalence across many different devices, providing technical support, ensuring privacy and security, and reimbursing participants for data usage. Future adoption of BYOD in clinical trials will require addressing these challenges.
This document outlines guidelines for telemedicine in India. It discusses the need for telemedicine, different modes of communication, guidelines issued by the Ministry of Health and Family Welfare, the framework and technology platforms for telemedicine. It also discusses success stories, challenges, and scenarios where telemedicine can be used, such as between patients and doctors, caregivers and doctors, health workers and doctors, and doctors consulting each other. The document provides detailed guidelines on the practice of telemedicine in India.
This survey of 300 doctors in Greater Jakarta area found that:
1) Online media is the most trusted source of medical information for doctors, followed by medical journals and seminars.
2) The internet has significantly influenced doctors' practice by allowing them to obtain information faster and be more active in seeking and sharing information.
3) Patients are increasingly looking up health information online, making them more informed but also more opinionated. Doctors have had to improve communication to discuss information patients find online.
4) While the internet provides many benefits, patient education remains a challenge requiring materials and training for doctors in properly educating patients.
Telemedicine is defined as using telecommunications to provide healthcare remotely by sharing medical information and expertise over distances. It involves transferring various medical data like images, sounds, and patient records via internet, intranet, computers, and telephone lines. Some key applications of telemedicine include teleconsultation, telemonitoring of patients, telediagnosis, and tele-education of medical practitioners. While telemedicine provides benefits like improved access to care and cost savings, its adoption faces challenges due to issues around technology infrastructure, licensing, and patient acceptance of remote healthcare.
ePRO_Presentation_BYOD Webinar_5 Final 9 March 2016 YPrimeCindy Howry, MS
This document summarizes a presentation on Bring Your Own Device (BYOD) for electronic clinical outcome assessments (eCOAs) in clinical trials. It discusses the growing interest in BYOD due to smartphone saturation and perceived benefits. There are two main types of BYOD apps: native apps downloaded from app stores and web apps accessed through mobile browsers. While BYOD could reduce costs and burden, challenges include demonstrating measurement equivalence across different devices, addressing logistical concerns, ensuring patient privacy and security, developing and supporting mobile apps, and reimbursing patients for data usage. Moving forward, these challenges can be overcome through careful study design, choice of appropriate app technologies, support structures, and patient reimbursement.
Telemedicine has moved to the forefront of healthcare, opening up opportunities for both practices and their patients. To help unpack some of the enormous amounts of new information, This presentation focuses on:
- Relaxing of Regulatory Issues
- How Telemedicine Can Help Your Practice
- Challenges
- The Future of Telemedicine
Craig lipset, Director of Clinical Research
at Pfi zer, leads a panel discussion on the
current state of clinical trials and the use
of technology to capture the voice of the
patient. Th e panelists, coming from various
backgrounds, lend their diff ering viewpoints
on the current and future trends in
this space
Mobile Phones - Always there and always on ! Vikrant Patnaik
mHealth is catching up and is now being considered to be used globally not only in the area of healthcare but also in the Pharma and Life sciences areas. This document speaks briefly about how mobility can be effectively used in Clinical Trials.
How Telemedicine Apps Prepares You for the Future of Remote HealthcareEMed HealthTech Pvt Ltd
Telemedicine app development is changing healthcare. It offers better access, convenience, and patient engagement. In the post-COVID era, one thing has become very clear: Technology and remote healthcare play a major role in the future of healthcare.
Traditional healthcare models are no longer suitable for today’s world. The rise of technology has transformed the approach to medical care.
If you are a healthcare provider that wants to succeed, EMed HealthTech is the answer you are looking for.
EMed HealthTech is ideal for customized telemedicine app development services.
Patient Compliance, ePRO and the Role of the CaregiverCRF Health
Sponsor companies are increasingly requiring methods like electronic patient-reported outcomes (ePRO) to ensure accurate and timely data collection from patients in drug trials. ePRO systems, like electronic diaries (eDiaries), have been shown to improve patient compliance compared to paper-based methods. eDiaries allow for real-time data entry and monitoring of compliance. ePRO can collect data from both patients and their caregivers, such as in pediatric studies or diseases affecting motor or cognitive function. Contrary to assumptions, the elderly and caregivers of children often have high compliance rates when using ePRO systems. Proactive eDiary design with simple questions, reminders and monitoring can help maintain compliance for diverse patient populations and study types.
Preparing for the Future Innovation in Digital Healthcare: Manas TripathiRahul Neel Mani
This document discusses various topics related to innovation in digital healthcare. It begins by describing different types of innovation, such as visible innovation for end users and invisible process innovation. It then provides examples of innovation, including how a hacker developed an innovative mosquito protection laser shield using common consumer electronics. The document also examines the transition to more patient-centric care from centralized medical facilities. It provides case studies on innovative portable e-backpacks in Brazil that expand access to remote communities and a UK program called Patient Access that improves patient experiences and reduces wait times through phone consultations.
This document discusses telemedicine, which is the delivery of healthcare via electronic services. It notes that patients, doctors, and insurance companies benefit from telemedicine. Patients find it more convenient than visiting a healthcare facility. Doctors can monitor remote patients and save time on cancellations. Insurance companies can process claims faster. The document outlines how telemedicine works from the patient's perspective and its benefits, such as improved access to care and cost efficiency. Potential challenges are also presented, such as electronic glitches, physician resistance, and inadequate assessment or training. Federal guidelines and advocacy groups help ensure telemedicine is safe and effective for patients.
7 Reasons Your Company Should Use A Digital Healthcare Solution.pptxMocDoc
Digital Healthcare Solution is one of the latest growing technology used by Healthcare Industries. So Here are the reasons why your company should use a Digital Healthcare
ENABLING AFFORDABLE HEALTH CARE SYSTEMS IN DEVELOPING COUNTRIES-CASE STUDYMehreen Shafique
Q1:
(a): What kinds of applications are described here?
(b): What Business Functions do they support:
(c): How do they improve operational efficiency and decision making?
Q2: Identify the problems that a business in this study solved by using mobile digital devices?
Q3: What kinds of Business are most likely to Benefit from equipping their employees with mobile digital devices such as I-Phones & Black Berry’s?
Q4: Devi Prasad Shetty’s CEO has stated “Now with 3-G, there are possibilities of remote treatment & diagnosis of patients through mobile phones. This will become mainstream in another two or three years.” DISCUSS the implications of this statement.
Using Interactive Media to Enhance Patient Experience and Create Brand Prefer...John Olson
The widespread adoption of interactive communication technologies has created consumer expectations for information that is personally relevant to them, available on-demand 24/7 via the Internet and increasingly via mobile web. This presentation gives case histories of healthcare organizations that have created interactive tools to meet these expectations, enhance patient experience and promote healing. Additionally, the presentation discusses how interactive media programs can be used to differentiate a provider organization and create competitive advantage.
This document discusses patient-centered drug development and clinical trials. It defines patient centricity as meaningfully including patients, particularly in trial protocol design, and linking clinical trial goals with patients' needs and experiences. It emphasizes measuring what matters to patients. While patient centricity is seen as important, there is no consensus on how to measure it. The document explores definitions of patient centricity, challenges in measuring it, examples of companies working to include the patient voice, and the need for new approaches to drug development that place greater focus on the patient experience.
This document discusses patient-centered drug development and clinical trials. It defines patient centricity as meaningfully including patients, particularly in designing trial protocols, and linking clinical trial goals with patients' needs and experiences. It emphasizes measuring what matters to patients. While patient centricity is seen as important, there is no consensus on how to measure it. The document explores how companies are working to include the patient voice, such as through patient advisory boards and surveys to capture patient perceptions and experiences in clinical trials. It argues that simply talking about patient centricity is not enough, and that meaningful action is needed to achieve it.
Does My Health Records Grooms Patient Or Medical Practice.pdfssuserbed838
My Health Records is very much in its beginning stage of benefiting people. Patients, providers, and physicians must look at it with a long-term view. Then it can critically become a tool in improving patient care.
Physicians are interested in adopting digital clinical tools if they:
1) Improve practice efficiency, increase patient safety, and enhance diagnostic ability.
2) Fit within existing systems and workflows.
3) Address concerns around data privacy, liability coverage, and reimbursement.
Physicians want to be involved in adoption decisions but also look to IT experts and practice leaders for guidance. Younger physicians see potential for tools to reduce burnout and strengthen patient relationships.
How to Protect Patient Data in an Increasingly Social Healthcare IndustryPerficient, Inc.
Connected care and social media are changing how patients interact with healthcare providers. This allows easier access to care and information for patients. It also helps providers improve quality, reduce costs, and increase efficiency through tools like remote monitoring, virtual visits, and care collaboration between patients and providers. However, organizations must ensure proper security and privacy of patient data as interactions move online and information is shared more widely.
Presentation by PJ Gorenc, Nemours Center for Health Delivery Innovation at the Smart Health Conference 2018, held at Bally's Las Vegas on the 26-27th of April, 2018.
Top 5 Key Features of Telehealth Software for Primary Care.pdfOmniMD Healthcare
These expectations can progressively make or break today's custom telehealth businesses and telemedicine software providers. Here are some essential features of this kind of software for primary care that will fulfill much of the needs of today's healthcare space and modern-day consumers.
1) Home and specialty infusion professionals widely embrace mobile health technology, with 83% using apps to reference drug or clinical information and 40% using apps to communicate with coworkers.
2) Popular clinical apps used include Epocrates, Lexicomp, Medscape, and Micromedex for drug information, and effective app features include leveraging smartphone capabilities, linking to external sensors, and securely transmitting data.
3) While apps can help improve patient engagement and care delivery, barriers remain around evidence, integration, privacy, and reimbursement, though the mobile health market is expected to reach $31 billion by 2020.
This document discusses how digital media can bring patients, staff, and hospitals together in healthcare. It describes how digital signage can reduce patient anxiety by educating them before procedures. It allows staff to more easily access patient information and locate each other. For hospitals, digital signage provides tools for advertising, fundraising, and reducing medical errors. The key is developing a strategy to implement these technologies effectively within the healthcare environment.
This document discusses how pharmaceutical companies can use digital health technologies like a patient engagement platform (PEP) to play a greater role in healthcare. A PEP would use tools like sensors, apps, and smart devices to collect patient data and provide personalized support to improve engagement, outcomes and costs. It could offer value to patients, physicians and payors. This allows pharma to address challenges and evolve their business model by demonstrating value, accessing physicians and providing value to payors.
Similar to Enabling Technology for Patient-Centered Clinical Trials (20)
This document discusses the myths and benefits of electronic informed consent (eConsent) compared to traditional paper consenting. It addresses 10 common myths, including that eConsent is not secure, participants prefer paper, and eConsent is less efficient than paper. The document argues that eConsent improves the consent process by increasing quality and consistency, improving participant understanding and experience, and reducing costs and regulatory findings compared to paper consenting. It provides examples of how eConsent can save significant costs by improving recruitment, retention, and reducing overall study timelines.
eConsent (electronic informed consent) adoption is on the rise!
100% of the Top 10 and 88% of the Top 25 Pharma have implemented eConsent - What's driving their adoption?
Learn more in our new infographic "14 Drivers of eConsent Adoption in Clinical Trials"
Q&A: The Internet of Everything in Clinical TrialsCRF Health
The Internet of Everything (IoE) allows physical devices and sensors to measure and send data without human intervention, enabling its application to clinical trials. IoE can capture better quality data, lower patient burden by reducing site visits, and provide a more complete picture of health through continuously captured data. While IoE use in clinical trials is growing, wider adoption of consumer IoE devices requires more regulatory guidance. Data security, privacy, and the potential for placebo effects also need to be addressed. IoE may increase efficiency by reducing paper use and enabling streamlined, electronic data collection and analysis in real time.
The document discusses how the Internet of Everything (IoE) could revolutionize clinical trials through connecting patients, data, and devices. Key points:
1) The IoE is being widely adopted across industries and could significantly benefit healthcare by applying it to clinical trials. This would allow continuous monitoring of patient data through connected devices.
2) An IoE system could remotely collect data from wearable devices and sensors, transmit it to servers for analysis, and enable real-time reporting. This offers benefits like instant access to risk factors and improved patient compliance monitoring.
3) While more data collection allows greater insights, challenges include evaluating large data volumes, ensuring privacy and security, and determining the best analysis protocols. Overall
Using eConsent in Clinical Research to Support Patient Understanding and WelfareCRF Health
Deciding to participate in a clinical trial is not risk-free for any participant. Some studies are designed for healthy volunteers and some are designed for participants with certain medical conditions.
Care Beyond Walls and Wires: Using Remote Monitoring to Enhance Patient CareCRF Health
About half of all adults in the US—117 million people—have one or more chronic health conditions, and the number is on the rise.1
In order to address this growing challenge, the Care Beyond Walls and Wires (CBWW) program was created to increase access to care and improve outcomes for patients suffering from chronic disease.
A collaboration between Qualcomm® Wireless Reach™, Northern Arizona Healthcare (NAH), Qualcomm Life, Inc., and Entra Health Systems, CBWW began as a congestive heart failure remote monitoring program.
Started in 2011, CBWW utilizes 3G/4G mobile broadband with connected home-use medical devices to enable nursing care coordinators to remotely monitor patients. As of 2017 the program is expanding to cover more patients with other chronic or high-risk conditions such as sepsis (blood poisoning from infection). The program aims to extend the delivery of care beyond the walls of hospitals by giving patients the tools to stay connected to providers – anytime, anywhere.
eConsent: Five (5) Key Areas of Preparation CRF Health
Site recruitment and retention of an adequate study population remains a major determinant of the success of a clinical trial. A recent survey to gather opinions on informed consent related to participant understanding, subject recruitment, and retention from 105 respondents' across site-based roles revealed 5 key areas that all sites should consider when preparing an eConsent.
Drivers of Remote Patient Monitoring (RPM)CRF Health
Remote patient monitoring devices that track patient data and send it to doctors can help patients better manage their conditions. Half of US hospitals now use telemedicine. One remote patient monitoring program saw a 75% reduction in hospital readmissions. The cost of healthcare in the US is expected to rise significantly by 2020 and 2030, but increased use of remote patient monitoring may save $200 billion over 25 years by improving care, enhancing patient satisfaction, and reducing costs.
Recruitment & Retention: Breaking Down the Barriers to eConsent AdoptionCRF Health
Informed consent is traditionally obtained through lengthy paper processes, but electronic informed consent (eConsent) offers improvements. eConsent uses multimedia to securely obtain and document informed consent, providing clear audit trails and version control. It facilitates participant comprehension and retention of study details. While sponsors are wary of new technologies, eConsent streamlines processes, provides oversight benefits, and aligns with regulators' views that consent should be an educational tool throughout a study. Integrating eConsent requires identifying practical solutions, but its rewards will contribute to improved outcomes in clinical trials.
Case Study: World's Largest COPD eCOA Trial Requires Reliability and Global S...CRF Health
CRF Health and its TrialMax® eCOA platform were adopted by a top 50 global pharmaceutical manufacturer to support one of the largest recorded phase III studies in chronic obstructive pulmonary disease (COPD). The trial, involving more than 19,000 patients in 35 countries, leveraged TrialMax® to deliver electronic versions of key COPD instruments, enabling investigators to monitor exacerbations while making compliance as easy as possible for patients.
With almost half of oncology studies failing due to a lack of patient retention, there is a critical need to develop more efficient and patient focused strategies. Jessica Thilaganathan at CRF Health sits down with International Clinical Trials to explain why electronic clinical outcome solutions could be the answer. (Published with permission of International Clinical Trials).
Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Prese...CRF Health
Patient-reported outcomes (PROs) are an
important means of evaluating the treatment benefit of
new medical products. It is recognized that PRO measures
should be used when assessing concepts best
known by the patient or best measured from the patient’s
perspective. As a result, there is growing emphasis on
well defined and reliable PRO measures. In addition,
advances in technology have significantly increased
electronic PRO (ePRO) data collection capabilities and
options in clinical trials. The movement from paperbased
to ePRO data capture has enhanced the integrity
and accuracy of clinical trial data and is encouraged by
regulators. A primary distinction in the types of ePRO
platforms is between telephone-based interactive voice
response systems and screen-based systems. Handheld
touchscreen-based devices have become the mainstay for
remote (i.e., off-site, unsupervised) PRO data collection
in clinical trials. The conventional approach is to provide
study subjects with a handheld device with a devicebased
proprietary software program. However, an
emerging alternative for clinical trials is called bring
your own device (BYOD). Leveraging study subjects’
own Internet-enabled mobile devices for remote PRO
data collection (via a downloadable app or a Web-based
data collection portal) has become possible due to the
widespread use of personal smartphones and tablets.
However, there are a number of scientific and operational
issues that must be addressed before BYOD can be
routinely considered as a practical alternative to conventional
ePRO data collection methods. Nevertheless,
the future for ePRO data collection is bright and the
promise of BYOD opens a new chapter in its evolution.
Equivalence of Electronic and Paper Administration of Patient-Reported Outcom...CRF Health
Objective
To conduct a systematic review and meta-analysis of the equivalence between electronic and paper administration of patient reported outcome measures (PROMs) in studies conducted subsequent to those included in Gwaltney et al’s 2008 review.
Methods
A systematic literature review of PROM equivalence studies conducted between 2007 and 2013 identified 1,997 records from which 72 studies met pre-defined inclusion/exclusion criteria. PRO data from each study were extracted, in terms of both correlation coefficients (ICCs, Spearman and Pearson correlations, Kappa statistics) and mean differences (standardized by the standard deviation, SD, and the response scale range). Pooled estimates of correlation and mean difference were estimated. The modifying effects of mode of administration, year of publication, study design, time interval between administrations, mean age of participants and publication type were examined.
Poster: Spirometer and eDiary Integration for Asthma TrialsCRF Health
An electronic asthma diary was developed with integrated spirometer functionality to reduce patient burden in asthma clinical trials. Feedback from sites and sponsors was used to refine the diary which can now directly transfer peak expiratory flow and forced expiratory volume measurements from a spirometer via Bluetooth. The streamlined diary led to high compliance rates of 88-92% in multiple global asthma studies and allows sites to remotely monitor patients' conditions between visits.
Poster: Equivalence of Electronic and Paper Administration of PROCRF Health
This systematic review and meta-analysis found high levels of equivalence between electronic and paper administration of patient-reported outcome measures (PROs). 435 correlations between paper and electronic versions showed good agreement (pooled correlation = 0.88). 355 estimates of mean differences between versions were also small (mean = 1.8% of scale score). Moderator analyses found greater agreement for more recent studies, randomized designs, shorter time intervals between versions, and older participant ages. The review concludes that PRO data from electronic and paper versions are comparable, supporting use of electronic administration in clinical trials and research.
Poster: Test-Retest Reliability and Equivalence of PRO MeasuresCRF Health
This literature review examined administration intervals used in test-retest reliability and equivalence studies for patient-reported outcome measures. The review found a large variance in intervals, ranging from immediate to 7 years for test-retest studies and from immediate to 1 month for equivalence studies. The most common intervals were 2 weeks for test-retest studies and 1 hour or less for equivalence studies. Intervals varied depending on the medical condition and type of study, with shorter intervals used for equivalence studies compared to test-retest studies for the same conditions.
Poster: eCOA Best Practices in Diabetes Clinical TrialsCRF Health
1) Managing diabetes involves regular blood glucose monitoring, tracking meals and insulin usage, which clinical trials seek to capture along with other patient-reported outcomes. This complexity can increase patient burden and lower compliance.
2) CRF Health created an electronic diabetes diary designed to limit additional burden on patients while accurately collecting needed clinical data. Usability testing found it less burdensome than paper methods.
3) Feedback from patients and sponsors identified challenges in diabetes data capture. CRF Health addressed these through design iterations informed by patient input, resulting in an intuitive interface that integrated glucose readings into event-based reporting.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell
Discover the groundbreaking advancements in stem cell therapy by R3 Stem Cell, offering new hope for women with ovarian failure. This innovative treatment aims to restore ovarian function, improve fertility, and enhance overall well-being, revolutionizing reproductive health for women worldwide.
2024 HIPAA Compliance Training Guide to the Compliance OfficersConference Panel
Join us for a comprehensive 90-minute lesson designed specifically for Compliance Officers and Practice/Business Managers. This 2024 HIPAA Training session will guide you through the critical steps needed to ensure your practice is fully prepared for upcoming audits. Key updates and significant changes under the Omnibus Rule will be covered, along with the latest applicable updates for 2024.
Key Areas Covered:
Texting and Email Communication: Understand the compliance requirements for electronic communication.
Encryption Standards: Learn what is necessary and what is overhyped.
Medical Messaging and Voice Data: Ensure secure handling of sensitive information.
IT Risk Factors: Identify and mitigate risks related to your IT infrastructure.
Why Attend:
Expert Instructor: Brian Tuttle, with over 20 years in Health IT and Compliance Consulting, brings invaluable experience and knowledge, including insights from over 1000 risk assessments and direct dealings with Office of Civil Rights HIPAA auditors.
Actionable Insights: Receive practical advice on preparing for audits and avoiding common mistakes.
Clarity on Compliance: Clear up misconceptions and understand the reality of HIPAA regulations.
Ensure your compliance strategy is up-to-date and effective. Enroll now and be prepared for the 2024 HIPAA audits.
Enroll Now to secure your spot in this crucial training session and ensure your HIPAA compliance is robust and audit-ready.
https://conferencepanel.com/conference/hipaa-training-for-the-compliance-officer-2024-updates
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfDr Rachana Gujar
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
Enabling Technology for Patient-Centered Clinical Trials
1. Driving the Industry Forward.1 FUTURE PHARMACEUTICALS
Patient as
the Source
Enabling technology
for patient-centered
clinical trials
To listen to the entire interview,
log on to www.FuturePharmaUS.com
2. 2www.FuturePharmaUS.com
clinical Research
CR
Craig Lipset, Director of Clinical Research at
Pfizer, leads a panel discussion on the current state
of clinical trials and the use of technology to capture
the voice of the patient. The panelists, coming from
various backgrounds, lend their differing viewpoints
on the current and future trends in this space
The People
Today’s patients strive to be informed and engaged. We’re witnessing
the rise of the e-patient: 61 percent of adults look online for health
information, 37 percent of adults are using health 2.0 resources such
as user-generated content, blogs and podcasts, and 42 percent of
adults believe they or someone they know have been helped following
medical advice online, according to the Pew Research Center.
The Challenge
The challenges for pharmaceutical companies are well known.
Pharmaceutical development cycles remain long and costly while
success rates remain low (16 percent of drugs entering clini-
cal trials receive approval). Over the last two decades, industry
investments in R&D have increased while the number of new
medicines introduced to the marketplace have fallen by about
half. Additionally major patent expirations are looming and there
is the influence of a rapidly changing external environment with
many unknowns such as healthcare reform and reimbursement.
The Question
Patients are better informed and engaged. What does this mean for
how we conduct clinical research?
Craig Lipset What are some of the touch-points for
engaging patients in clinical trials and how are we
engaging patients today?
Tim Davis It isn’t all doom and gloom. Speaking from our own experience
and from our customer feedback, one of the clearest touch points in the
world today is the mobile or cell phone channel. Over 4 billion people or
two-thirds of the world’s population already own a cell phone and that is
three times the number of people who have access to the Internet (either at
home, work or in an Internet cafe) or who own a tethered landline telephone.
Therefore, it is common sense that this is a platform for patient engagement
and we’ve seen that this can be really effective in areas of patient recruit-
ment, patient compliance, long-term retention and motivation using a simi-
lar modality, right through to actually using the cell phone as an electronic
diary that patients carry around with them every day to collect data regard-
ing their condition, symptoms etc. »
3. Driving the Industry Forward.3 FUTURE PHARMACEUTICALS
Patient as the source
Mr. Lipset brings over 15 years of leadership and innovation in
clinical research. At Pfizer he leads initiatives in molecular medi-
cine to advance personalized therapies, as well as in eHealth le-
veraging technologies to improve patient engagement in clinical
research. He previously served as VP of Program Management at
Adnexus Therapeutics (formerly Compound Therapeutics) with
responsibility for clinical and regulatory affairs. Mr. Lipset was
recently awarded the 2010 DIA Outstanding Service Award.
Craig Lipset
Director of Clinical Research
Pfizer
Mr. Federico is responsible for managing all aspects of the ePRO
Solutions suite at ERT, including product development, operations,
and sales. The ePRO group has organized ERT’s capabilities into
products and services to provide the complete patient experi-
ence from recruiting right through to suicidality monitoring. New
products within the portfolio include new scales, diaries, Time-
Line-Follow-Back, suicidality monitoring assessment and alerting
services. ERT also offers established protocols for validating new
ePRO services.
Michael Federico
Vice President
ePro Solutions, ERT
CRF Health Inc., is a leading ePRO software and services provider.
Mr. Jordan is responsible for the Global Operations and leads the
Client Services group within the organization. Prior to joining CRF
Health, Mr. Jordan was the Global Head of EDC and ePRO and As-
sistant Director of Global Clinical Data Management at Schering-
Plough Research Institute and was responsible for the Clinical
Database Services (CDS) department. The CDS group managed
and performed the development of the EDC portion of all studies
conducted by SPRI.
John Jordan
Chief operating officer
CRF Health Inc.
Karin Coyne Patients today enjoy technology. They like to try out devices,
they like feedback and they want to use an interface that is easy to use, which
requires very little instruction in order to complete. They like the immediate
feedback that can be provided with electronic technology. In terms of recruit-
ment, we have been able to recruit online very rapidly. It greatly enhances
how quickly we can recruit and enroll patients for our studies.
John Jordan At CRF Health we’re involved with electronic patient reported
outcomes and that is where I see most of the engagement with patients at
this point in time. The electronic patient reported outcomes process with
regards to providing hand-held PDAs to the subjects and allowing them to
enter data directly to the clinical trial database gives them a certain power
and involvement that hasn’t been seen in many years. In addition to the PDA
handheld solution we provide, I agree with Tim that the mobile phone is
becoming more of a touch point for the patient. With regards to the mobile
phones there are functionalities available to send reminders or alarms to
patients or SMS text messages as well to ensure the compliance and proto-
cols are followed in the proper manner.
Mike Federico What we’ve seen when engaging patients is the necessity
to use a simple but powerful solution that every subject is comfortable with
and that they can then use throughout the patient experience. We’ve found
that using the telephone, as Tim mentioned, is something that is very famil-
iar to them and we’re talking about just a regular telephone that has broad
applicability. The success is in the simplicity of the ‘low tech’ solution. Major
advantages of using this technique are that you avoid the illiteracy and com-
prehension problems, access difficulties and hardware issues.
Using something very familiar to your patients, the telephone, will get
them involved in your clinical trials early and establish both buy-in and a
direct line of access, which ensures that the patients will feel they’re being
looked after. As the study progresses, patients remain involved through-
out the process, using the phone to perform assessments and screening,
fill in electronic diary entries, and collect clinical assessments and safety
monitoring data, until completion of your trial. Then as you move them into
open label they’re still using the same simple patient interface to do ongo-
ing monitoring throughout a Phase IV trial. If we can simplify the interface
with the patient; give them something they already know how to use, and
have one modality throughout the patient experience, it is going to provide
the most simple touch point and engage all patients throughout the trial
and their ongoing care.
CL What are the various types of data we capture from
the patient as source?
JJ The types of data that is captured in various clinical trials throughout the
industry varies a great deal. In most cases when people hear the acronym
ePRO (electronic Patient Reported Outcomes) most of the time what comes to
mind is quality of life questionnaires, signs and symptoms, or compliance with
taking medication at the prescribed time. In addition to the quality of life and
additional questionnaires that are typically used in ePRO, we also have vari-
ous dosing modules that are being utilized right now where pharmaceutical
companies are requiring patients to take various medication at various times
throughout the day, and ensuring that they are taken at the right times is criti-
cal to the success of their trials. So the scope of the data that is being collected
is growing rather quickly within the industry. The expansion and adoption of
ePRO is growing quickly as well. In addition to the data sources that I’ve spo-
ken about, there will be many more to come in the years ahead.
MF Patient Reported Outcomes via, in this case, the telephone provide for a
broad range of data we would like to collect — whether it’s initial recruitment
information or data collected during the trial. The PRO guidance defines PRO
as taking information from the patient without it being processed by another
human being. This is a great example of where PROs can be done electroni-
cally without that interface of someone sitting across from the patient con-
ducting an interview or a clinical assessment and it then being processed
through them and before finally being entered into the database. With the
electronic PRO we can capture that data directly from the patient, whether
it’s a screening criteria, quality of life data or a clinical assessment.
The other aspects of the trial affected are around safety data and, in par-
ticular, suicidality monitoring is a hot topic for the regulatory agencies at the
moment. As an industry, we want to be able to capture that this sort »
4. Driving the Industry Forward.5 FUTURE PHARMACEUTICALS
Patient as the source
Mr. Davis co-founded Exco InTouch Ltd, an interactive mobile so-
lutions company delivering innovative mobile solutions for patient
recruitment, compliance and real-time data collection in both
clinical and commercial settings. Mr. Davis has been a speaker
and chairman on the conference circuit since 2000; specializing
in the subjects of EDC, e-PRO, implementation of new technolo-
gies and electronic source data. He has also written and published
several articles around these subjects as well as being a member
of the ICR’s Special Interest Group on Patient Recruitment.
TIm Davis
Ceo & co-founder
Exco InTouch
Dr. McKenzie is a Senior Scientist and Director of Clinical Affairs,
Bend Oregon Division, Philips Respironics Company. He was the
Director of the Center for Excellence in Cardiovascular Medicine
and served on the NIH, NHLBI, Research Manpower Review Com-
mittee and the Training Review Committee. For the past twelve
years Dr. McKenzie has been involved in the development and
integration of objective ambulatory physiological monitors.
Jack McKenzie
Director of Clinical Affairs
Philips Respironics
Dr. Coyne’s responsibilities include instrument development and
validation as well as design and management of research studies
focused on patient-reported outcomes. Areas of expertise include
cardiovascular, urology, gastrointestinal, diabetes and women’s
health. Dr. Coyne has extensive experience in all phases of instru-
ment validation and development.
Karin Coyne
Senior Research Leader
United Biosource's Center
for Health Outcomes Research
of safety information directly from the patient without it being monitored or
assessed by another human being. The fact that we’re getting the informa-
tion directly from the patient without additional processing or interpretation
means we will be getting more accurate and credible data.
Jack McKenzie In the past, due to the limits in technology, physiologi-
cal data was only collected in clinical settings. With the advancements
that have been made in the technology of developing physiological mea-
surements, we now can collect objective data in the patients’ ambulatory
environment. This decreases the noise-to-signal ratio so if you have an
objective measurement, there is a better signal with less noise. In addition,
it reduces the patient burden. For example, the FDA was looking at the
fatigue rating scale of a pharma study and decided they need an objec-
tive way to measure fatigue. In this case they used actigraphy to measure
the activity of daily living, the number of naps, and the sleep the patient
was getting. I think in order to measure the quality of life indicators that
have been mentioned before, it is really important that we start to look at
the physiological measurements and how those measurements align with
some of the subjective measurements that are being collected.
CL What are some of the challenges to successful
implementation of tools designed to capture the
“voice” of the patient?
KC There are quite a few. Certainly how you ask a question alters the
response of that question. How a question is presented, be it via phone,
Web or PDA, will also affect the response, which is why user interface is so
essential. There is a need to make sure that the instructions are clear and
the answers are easy to select without, for instance, changes caused by the
mouse without the patient knowing it. It is a blending of science and technol-
ogy when we take a questionnaire or PRO from paper and place it onto any
type of device or electronic interface.
Also, the final FDA guidance document highlights the point that you
need to keep the format consistent with how it was originally developed.
The wonderful thing about moving from a paper medium to electronic is
that you can enhance the PRO and make it easier especially if there is a
skip pattern involved. When going from a paper to an electronic modality
if subtle things are changed, and typically they are especially with instruc-
tions and formatting, you need to verify that the intent or the meaning of
the questions has not changed.
There are a few other challenges involved with this transition but they
can be addressed with patient interviews and usability testing, which is
critical when going from one format to the other.
JM One of the interesting things we in the industry need to address is the
standardization of signals. For example, it is very easy to say a patient has
a certain heart rate or respiratory rate, but when you get to other signals
such as activity of daily living as recorded by accelerometers, or sleep, there
needs to be standardization of those signals and of those reported out-
comes to the FDA and to the regulatory bodies.
The other barrier that we’re facing is the FDA’s acceptance of physiologi-
cal data. The best example is in the field of sleep. Right now the gold stan-
dard is polysomnography for insomnia, but polysomnography is not being
reimbursed for insomnia whereas actigraphy is. We need to educate the FDA
on the end points and how to move those end points forward. I think the
other primary end point that we need to think about in measuring physiolog-
ical is how to best get those to the patient with the least amount of invasion
into their ambulatory structure.
TD We’ve seen the ePRO guidance which is very much how we expected
it to be, there weren’t any tremendous road blocks for any of the vendors
involved in this phase. With regards to that regulation and also 21 CFR
Part 11 I think now the majority of vendors can really show the validation
credibility and regulatory rigor demanded by sponsors. The majority of
responsible organizations are comfortable with the approach and the
delivery taken.
With regards to HIPAA and HIPAA equivalents around the world, we are
quite fortunate in a sense that we are working in 60 countries and have a
good insight into that. HIPAA itself is fairly easy to manage within the clini-
cal trials framework because it is handled and wrapped up quite neatly in
the informed consent process. You have informed consent from the »
5.
6. Driving the Industry Forward.7 FUTURE PHARMACEUTICALS
Patient as the source
patient to use their data for what the investigators refer to as medical his-
tory, so that is perfectly OK.
That may change in the future if we start to look at electronic medical
records and electronic hospital records where we may be accessing an elec-
tronic view or extrapolating data directly from an electronic medical record
source. With that in mind, that is where HIPAA would potentially come into
play. With privacy, I think the models are acceptable, although we are see-
ing issues in some western European countries around certain sensitive dis-
eases such as HIV, where patients are reluctant to transmit data outside of
the borders of their own country. This is one of the challenges we have to
accept and it is a matter of staying in touch with the regulatory authorities
and helping them with their understanding of the technology.
KC This is certainly a prime opportunity to add in more questions that are
related to safety and other attributes about a study that sponsors might
be interested in. Make sure the questions, although they might be new, are
tested and used in the lay public before implementing on a live scale. This is
because you may find that there will be questions that make perfect sense,
but once the questions are tested on a larger cohort they are not being inter-
preted in the way they were intended. When taking any type of question,
whether it is part of a standard PRO or just new questions developed for
other reasons, it is always good to test in a lay public population first.
CL What new opportunities exist to improve our
engagement with patients in clinical trials? New tools?
New models?
TD If I gaze into the crystal ball, I think you could look at any sort of disrup-
tive change. There are always economics that play a key factor. We have sig-
nificant changes coming in economic and clinical trials. We are being asked
by the FDA and the other regulatory bodies throughout the world to extend
patient monitoring. In clinical trials there will be a Phase II as we will know
it, but then the Phase III will become more of an open-label, much larger
approach where the tracking of the patient may well extend through the test-
ing phase to the point where there will be a long-term monitoring initiative
taken. The key will be finding what platform patients are going to be most
comfortable with. Clinical trials will have to adapt and we will see a large
uptake in technology.
KC Things will change. They have to change. And certainly technology will
take us into the future of enabling longer term follow-up and multiple plat-
forms will have to be used. However, there will need to be consistency within
the trial. Technology will have to be consistent so you are not entering ran-
dom error into your outcomes. I think a Web-based interface — whether on
the computer or a PDA tablet in a physician’s office or a smart phone — that
can be provided to patients is one way you can keep a consistent technol-
ogy, although with slightly different interfaces. I think there will be a growth
in terms of how these are utilized in the future, in how you can provide
feedback directly to patients that can help them make decisions and help
improve outcomes down the road.
JJ Integration among the platforms that are out there right now. All of the
different platforms are being utilized by various sites throughout the globe.
The integration of those platforms is crucial for expansion and adoption of
technology within the clinical trial industry. The integration that needs to
take place between the various devices and different data capture tools
that are out there now are really going to depend on the push from regu-
lators. We need to have regulations around capturing this data and mak-
ing the data work better for the sites, and in turn allowing the sites to work
better for the patients.
MF Once we can put the focus on the patient and use one simple interface
with them throughout their life cycle, not just one trial subject lifecycle, then
I see that as the future — by focusing on the patient.
JM I think our responsibility as the device industry is to improve ambula-
tory physiological monitors. I think these have to be transparent devices.
Once you put something on a subject, then all of a sudden it is like being
watched by “big brother.” We need to develop an ambulatory physiological
monitor that is transparent and really blends in with their everyday activi-
ties. The other piece of that is the transmission of data has to be in real
time. The future is data in real time. Moving forward we need to integrate
the physiology with the questionnaires.
CL What changes are needed for us to enable this future?
JM From my standpoint, I really believe education is the most important
thing. We need to educate ourselves on: What are the technologies and
what do they look like? We need to educate the pharmaceutical world on
the potentials they have for measuring whatever it is to make the drug better
and to make the measurements of that drug more sophisticated. We really
need to educate the FDA on the new technologies out there and what we can
we provide for them.
MF The ePRO sector now has a basis by which to work with the regulators
and cut down some of the barriers and hurdles. One thing we love about our
industry is its consistency, but another word for consistency is inertia. And
certainly there is a lot of that in the industry. Anything we can do to work
directly with the regulators to remove that fear of change, anything we can
do to facilitate doing more accurate electronic methodologies and get better
data from the patients, will ensure better patient engagement and quality of
both information and treatment.
KC One of the biggest challenges enabling technology integration in
the future is working through logistics – working through how to inte-
grate the technology and new processes into the current clinical trial
operations; through clinical trial design, through site training, through
patient recruitment. Technology affects every facet, and it can certainly
make things much easier, but there is a tremendous logistical process
that needs to be rethought to accommodate how technology can be inte-
grated into this process.
JJ The driving force of a lot of things we do in this industry comes from the
regulators and the FDA. Having the FDA looking at a bigger picture and
understanding the scope of the integration that is required to make a lot of
these technologies work is critical in the acceptance of it in the future. Not
all of the clinical sites are large hospitals or universities, and some of these
smaller sites have a great deal of burden put on them when they need to uti-
lize these technologies. Working with the regulators to perhaps certify them
as “e-research ready,” or some sort of a process that will enable the sites
and investigators to utilize these technologies better, I think really needs to
come from the regulators.
TD When looking at this question, I was thinking of EDC as an example of
something that had some scale-up. I did my first EDC study in 2000, and at
that point a survey was done that said less than 10 percent of clinical studies
were done that way. About a month ago, there was a survey that said 60 to 70
percent of studies were done on EDC. I think in an industry that does suffer
quite a lot of inertia, that is pretty good progress. I thought about what has
driven that uptake? It is really being driven by all the stakeholders realizing
this is the way forward. They have seen the benefit, but it has taken eight or
nine years to see the positive impact, and how it improves their daily routine.
In this second generation, we have to continue to get people to see the tech-
nology in action. We have to make sure the sites are happy, and they get their
benefits, and that the patients are comfortable and engaged as welll. FP